A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment
Clinical trial NCT05597085 · COMPLETED
Trial details
- NCT number
- NCT05597085
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-08
- Primary completion
- 2023-07-10
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.